ObjectivesMuscadine wine has a unique polyphenol profile consisting of anthocyanin 3, 5-diglucosides, ellagitannins, ellagic acids, and flavonols. This study aimed to determine whether dealcoholized muscadine wine (DMW) alleviated inflammatory bowel diseases (IBD) in IL-10–/– mice. MethodsDMW was prepared by concentrating muscadine wine to 10% of its original volume. Male IL-10–/– and wild-type C57BL/6 mice (6∼7-week-old) were fed an AIN-93M diet containing DMW (5.5%, v/w) or wine-free diet for 154 days. Body weight, food intake, stool consistency, rectum bleeding, and disease activity index of mice were recorded twice a week. Colon, spleen, and serum were collected after euthanasia for histological and biochemical analysis. Fluorescence of serum were measured 4 hours after oral gavage of fluorescein isothiocyanate (FITC)-dextran to determine the intestinal permeability. ResultsIL-10–/– mice developed ulcerative colitis, inflammation, and impaired gut barrier spontaneously whereas wild type mice remained healthy. DMW in diet preserved colon length and decreased colon histology score by 21.2% in IL-10–/– mice (P < 0.05). IL-10–/– mice on DMW diet had a significantly lower disease activity index than those on wine-free diet. Serum level of keratinocyte chemokine, IL-1β, and TNF-α were decreased by 31.8%, 62.8%, and 29.3% (P < 0.05), respectively, by DMW in IL-10–/– mice, whereas IL-6 remained unchanged. Compared to the wine-free diet, concentration of FITC-dextran in the serum of IL-10–/– mice were decreased by 18% by DMW (P < 0.05), indicating improved intestinal barrier function. DMW had no effect on wild type mice. IL-10–/– mice had comparable body weight to wild type ones although their overall food intake was lower. ConclusionsDMW alleviated colon inflammation via inhibiting the secretion of inflammatory cytokines and preserving intestinal barrier. Muscadine wine has a potential to manage IBD in patients. Funding SourcesThis research is supported by NIFA 2018–07,941.
Read full abstract